MedPath

A Clinical Study With Homoeopathic Treatment In The Management Of Attention Deficit Hyperactivity Disorder in Children Aged 6- 15 years

Phase 4
Conditions
Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
Registration Number
CTRI/2021/03/031807
Lead Sponsor
S SAHANA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children under - Multidisciplinary treatment.

Children fulfilling the criteria of the Swanson, Nolan and Pelham Parent and Teacher Rating Scale

(SNAP IV)

Exclusion Criteria

Patients Who Have Oppositional defiant disorder, Intermittent explosive disorder, Specific learning disorder, Intellectual disability, Autism spectrum disorder, Reactive attachment disorder, Anxiety disorders, Depressive disorders, Bipolar disorder, Disruptive mood dysregulation disorder, Substance use disorders, Personality disease, Psychotic disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected that the proposed study will be useful in reducing the symptoms of Attention Deficit Hyperactivity in children aged 6-15 years.Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
It is expected that the proposed study will be useful in reducing the symptoms and improving quality of Attention Deficit Hyperactivity in children aged 6-15 years <br/ ><br>The prognosis is done using the Swanson, Nolan And Pelham Parent and Teacher Rating Scale (SNAP IV) at the end of 6 monthsTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath